Kos Pharmaceuticals, Inc (KOSP) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Kos Pharmaceuticals, Inc (KOSP)

An SI Board Since March 1997

Posts	SubjectMarks	Bans	Symbol
118	20	0	KOSP

Emcee: DD™	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
68	Wrong stock. MIKE	Michael Young	-	5/15/2002
67	I suppose you have seen that Adams, Harkness & Hill has initiated coverage o	Icebrg	-	5/15/2002
66	Thanks for the link. I am a shareholder and a patient. It hurt Kos's stock	robert miller	-	5/11/2002
65	Deutsche Bank KOS Pharmaceuticals at Deutsche Bank Health Care 2002 Conference	Icebrg	-	5/11/2002
64	>>Kos First Quarter Revenue Increases 136 Percent To a Record $34 Million	tuck	-	5/10/2002
63	Almost bought some KOSP yesterday and am sorry I didn't. It beat estimates	tuck	-	2/21/2002
62	>>RESEARCH TRIANGLE PARK, N.C., Jan. 30 /PRNewswire-FirstCall/ -- Quintile	tuck	-	1/30/2002
61	tuck, Here's another nice quote from that Alex Brown rec: <i>Taken t	Biomaven	-	12/21/2001
60	FWIW, Alex Brown's David Steinberg weighs in: >>For Kos Pharmaceutica	tuck	-	12/20/2001
59	And yet more from Medscape, Triglyceride Levels Predict Stroke and TIA Risk in	robert miller	-	12/15/2001
58	Good news for Advicor from Medscape, ApoB and ApoA-I May Be Better Predictors o	robert miller	-	12/15/2001
57	Hi quid, I hope someone else can help with your question. I do not understand	IRWIN JAMES FRANKEL	-	12/11/2001
56	Included in Merck's earnings 2002 warning was this note on Zetia, a statin d	quidditch	-	12/11/2001
55	Hi rkrw, I don't think that KOSP in it's current condition is subject t	IRWIN JAMES FRANKEL	-	12/4/2001
54	<i>I don't understand why these shares aren't included in the wtd	Biomaven	-	12/4/2001
53	An incredible believer and an incredible investment. Assuming these shares wi	rkrw	-	12/4/2001
52	<Am I reading this right?> I read it the same way. Do you think Jahari	IRWIN JAMES FRANKEL	-	12/3/2001
51	Why switch to Advicor when you can take niaspan along with a superior statin, li	rkrw	-	12/3/2001
50	Advicor might take sales away from Niaspan, but I think it will add more than it	robert miller	-	12/2/2001
49	IJ, The cholesterol market is driven by primary care physicians. It's a mir	Biomaven	-	12/1/2001
48	Niaspan has been out for several years. I have been tracking the scripts in an	IRWIN JAMES FRANKEL	-	12/1/2001
47	and Sharck said let there be life.... LONG KOSP, report to follow....	Sharck	-	12/1/2001
46	Irwin, Why do you think the ramp has been modest. The rund rate is approaching	Vector1	-	11/30/2001
45	Hi Vector, I have re-entered KOSP after being out for quite a while. (The ramp	IRWIN JAMES FRANKEL	-	11/30/2001
44	Michael, It is time for this thread to come back to life. This stock has huge p	Vector1	-	11/30/2001

Go to reply# or date (mm/dd/yy):